Researches have demonstrated that the integrin α-v-β6 expressed by tumor cells is capable of activating latent forms of transforming growth factor (TGF)-β, a well-known stimulator that induces the differentiation of quiescent fibroblasts into CAFs in TME (Hawinkels et al., 2014). Here, TGFB1 is linked to neoplasm.